Pharmacology
 |
|
5 february 2019 15:03:21 |
| Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? (Pharmacogenomics Journal) |
|
Tweet |
| 80 viewsCategory: Genomics, Pharmacology |
 Patient-provider communications about pharmacogenomic results increase patient recall of medication changes (Pharmacogenomics Journal)Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors (Pharmacogenomics Journal) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
